Please assess the completion status of the following clinical trial:

Trial Title: A Study to Evaluate THB001 in Adult Patients With Chronic Cold Urticaria

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SEQUENTIAL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 3.0

Eligibility Criteria:
Key Inclusion Criteria:~1. Women and Men ages 18-75~2. Diagnosed with chronic, cold inducible urticaria for at least 3 months prior to starting the study and refractory to antihistamine treatment~3. Positive cold stimulation test assessed by TempTest® at the Screening and Baseline visits~4. Considered healthy as assessed by medical evaluation including review of medical history, physical examination, vital signs, laboratory tests and ECG recording~5. Willing and able to participate in all visits, undergo all study procedures and adhere to study restrictions~Key Exclusion Criteria:~1. A diagnosis of acute urticaria or non-cold chronic inducible urticaria~2. Ongoing treatment with immunosuppressant drugs (corticosteroids, cyclosporine, azathioprine, methotrexate, omalizumab, dupilumab, sulfasala-zine, dapsone or others)~3. A positive test for pregnancy, HIV, Hepatitis B or Hepatitis C~4. Clinical laboratory values outside of the normal ranges at the Screening visit~5. History of any clinically significant abnormality that would contraindicate participation~There are additional criteria that your study doctor will review with you to confirm you are eligible for the study.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- THB001 Dose Level A (Type: EXPERIMENTAL): None
- THB001 Dose Level B (Type: EXPERIMENTAL): None
- THB001 Dose Level C (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).